Literature DB >> 18646314

HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions.

Tamika D Campbell1, Mahfuz Khan, Ming-Bo Huang, Vincent Craig Bond, Michael D Powell.   

Abstract

HIV-1 Nef is a major determinant in HIV-1 pathogenicity. However, its properties have mainly been associated with its biochemical activities within the producer cell. Nef is also secreted from infected and transfected cells. Our primary objective was to determine the nature of secreted Nef protein and its effect on target cells. We determined that HIV-1 Nef is secreted in the form of exosome-like vesicles. Nef protein present in these vesicles is largely protected from protease digestion, which suggests that most of the protein is present on the lumenal side of the vesicles. We observed that HEK293 cells, transfected with a Nef-GFP expression vector, can secrete vesicles containing Nef-GFP fusion protein into the extracellular medium. When the conditioned medium was used to treat Jurkat cells, we found that the cells can take up the Nef fusion protein. The pattern of distribution of the Nef-GFP fusion protein within the target cells is mainly cytoplasmic and results in a punctate staining pattern. We also observed that Nef (-) virions treated with Nef-conditioned medium have their infectivity restored to near wild-type levels. This implies that the Nef contained within vesicles has the ability to fuse with HIV-1 virions and deliver functional Nef to these virions. It also demonstrates that Nef protein delivered in trans can restore infectivity even after virion maturation has occurred. These studies suggest that secreted Nef could play a role in HIV-1 pathogenesis by inducing effects in noninfected bystander cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18646314      PMCID: PMC3418053     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  16 in total

1.  Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.

Authors:  Cleve O James; Ming-Bo Huang; Mafuz Khan; Minerva Garcia-Barrio; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.

Authors:  Simone I Giese; Ilka Woerz; Stefanie Homann; Nadine Tibroni; Matthias Geyer; Oliver T Fackler
Journal:  Virology       Date:  2006-08-17       Impact factor: 3.616

4.  Mutational analysis of the HIV nef protein.

Authors:  B Guy; Y Rivière; K Dott; A Regnault; M P Kieny
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

Review 5.  HIV accessory proteins: leading roles for the supporting cast.

Authors:  D Trono
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

6.  Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix.

Authors:  T M Niederman; W R Hastings; L Ratner
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

7.  Fusogenic activity of amino-terminal region of HIV type 1 Nef protein.

Authors:  C C Curtain; F Separovic; D Rivett; A Kirkpatrick; A J Waring; L M Gordon; A A Azad
Journal:  AIDS Res Hum Retroviruses       Date:  1994-10       Impact factor: 2.205

8.  Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.

Authors:  S Anderson; D C Shugars; R Swanstrom; J V Garcia
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.

Authors:  Mahfuz Khan; Lingling Jin; Ming Bo Huang; Lesa Miles; Vincent C Bond; Michael D Powell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 10.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.

Authors:  K Denzer; M J Kleijmeer; H F Heijnen; W Stoorvogel; H J Geuze
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  63 in total

Review 1.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

3.  Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ(1-42) secretion in SH-SY5Y neural cells.

Authors:  Mahfuz B Khan; Michelle J Lang; Ming-Bo Huang; Andrea Raymond; Vincent C Bond; Bruce Shiramizu; Michael D Powell
Journal:  J Neurovirol       Date:  2015-09-25       Impact factor: 2.643

Review 4.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

5.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 6.  Exosomes and other extracellular vesicles in host-pathogen interactions.

Authors:  Jeffrey S Schorey; Yong Cheng; Prachi P Singh; Victoria L Smith
Journal:  EMBO Rep       Date:  2014-12-08       Impact factor: 8.807

7.  Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals.

Authors:  Kateena Addae Konadu; Jane Chu; Ming Bo Huang; Praveen Kumar Amancha; Wendy Armstrong; Michael D Powell; Francois Villinger; Vincent C Bond
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

8.  Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs".

Authors:  Guoku Hu; Sowmya Yelamanchili; Fatah Kashanchi; Norman Haughey; Vincent C Bond; Kenneth W Witwer; Lynn Pulliam; Shilpa Buch
Journal:  J Neurovirol       Date:  2017-11-16       Impact factor: 2.643

Review 9.  Extracellular vesicles and infectious diseases: new complexity to an old story.

Authors:  Jeffrey S Schorey; Clifford V Harding
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

Review 10.  Exosomes in Viral Disease.

Authors:  Monique R Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.